News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

R-Tech Ueno Announces Result of Arbitration Against Takeda Pharmaceutical Co. Ltd. (TKDG.DE)



7/6/2012 9:34:25 AM

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) has announced The International Court of Arbitration, International Chamber of Commerce (“ICC”), has issued its arbitral award in the arbitration filed by R-Tech Ueno, Ltd., together with Sucampo Pharmaceuticals, Inc. (“Sucampo”) and Sucampo AG, against Takeda Pharmaceutical Company Ltd. (“Takeda”). The arbitral award stipulated that the claims of R-Tech Ueno were not accepted and the Supply Agreement among R-Tech Ueno, Takeda and Sucampo executed in 2004 regarding the exclusive supply of AMITIZA® capsules shall continue to be in effect. No damages were rendered.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES